nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACE inhibitor and angiotensin II antagonist combination treatment
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S98-S99 |
artikel |
2 |
ACE inhibitor treatment in diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S79-S91 |
artikel |
3 |
Acidosis
|
Johnson, David |
|
2006 |
|
s1 |
p. S33 |
artikel |
4 |
Analgesic-associated kidney disease
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S123-S125 |
artikel |
5 |
Angiotensin II antagonists
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S92-S97 |
artikel |
6 |
Antihypertensive therapy in diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S73-S78 |
artikel |
7 |
Autosomal-dominant polycystic kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S52-S56 |
artikel |
8 |
Blood pressure control: role of specific antihypertensives
|
Gillin, Adrian |
|
2006 |
|
s1 |
p. S60-S65 |
artikel |
9 |
Blood pressure control: targets
|
Gillin, Adrian |
|
2006 |
|
s1 |
p. S55-S59 |
artikel |
10 |
Calcineurin inhibitors in paediatric renal transplantation
|
McTaggart, Steven |
|
2007 |
|
s1 |
p. S106-S110 |
artikel |
11 |
Calcineurin inhibitors in renal transplantation: adverse effects
|
Jose, Matthew |
|
2007 |
|
s1 |
p. S66-S74 |
artikel |
12 |
Calcium
|
Hawley, Carmel |
|
2006 |
|
s1 |
p. S198-S200 |
artikel |
13 |
Calcium × phosphate product
|
Hawley, Carmel |
|
2006 |
|
s1 |
p. S206-S208 |
artikel |
14 |
Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes
|
Pilmore, Helen |
|
2007 |
|
s1 |
p. S88-S97 |
artikel |
15 |
Clinical diagnosis of kidney stones
|
Thomas, Mark |
|
2007 |
|
s1 |
p. S1-S3 |
artikel |
16 |
Control of hypercholesterolaemia and progression of diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S116-S119 |
artikel |
17 |
Cystine stones
|
Becker, Gavin |
|
2007 |
|
s1 |
p. S4-S10 |
artikel |
18 |
Dietary protein restriction
|
Johnson, David |
|
2006 |
|
s1 |
p. S2-S14 |
artikel |
19 |
Early detection of patients with kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S37-S40 |
artikel |
20 |
Early referral of patients with pre-end-stage kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S41-S43 |
artikel |
21 |
Erythropoietin
|
Johnson, David |
|
2006 |
|
s1 |
p. S34-S40 |
artikel |
22 |
Exercise
|
Johnson, David |
|
2006 |
|
s1 |
p. S30-S32 |
artikel |
23 |
Focal segmental glomerulosclerosis: correction of secondary causes
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S194-S195 |
artikel |
24 |
Focal segmental glomerulosclerosis: cytotoxic therapy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S189-S193 |
artikel |
25 |
Focal segmental glomerulosclerosis: treatment with steroids
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S182-S184 |
artikel |
26 |
Focal segmental glomerulosclerosis: use of cyclosporin A
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S185-S188 |
artikel |
27 |
Focal segmental glomerulosclerosis: use of other therapies
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S196-S197 |
artikel |
28 |
Foreword
|
|
|
2006 |
|
s1 |
p. S1 |
artikel |
29 |
Glucose control and progression of diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S109-S113 |
artikel |
30 |
Idiopathic membranous nephropathy: use of other therapies
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S172-S174 |
artikel |
31 |
Iron
|
Roger, Simon |
|
2006 |
|
s1 |
p. S217-S229 |
artikel |
32 |
Kidney stones epidemiology
|
Hughes, Peter |
|
2007 |
|
s1 |
p. S26-S30 |
artikel |
33 |
Lipids
|
Johnson, David |
|
2006 |
|
s1 |
p. S15-S24 |
artikel |
34 |
Membranous nephropathy: role of alkylating agents
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S154-S161 |
artikel |
35 |
Membranous nephropathy: role of cyclosporin therapy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S166-S169 |
artikel |
36 |
Membranous nephropathy: role of steroids
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S162-S165 |
artikel |
37 |
Metabolic evaluation
|
Hughes, Peter |
|
2007 |
|
s1 |
p. S31-S33 |
artikel |
38 |
Multifactorial therapy and the progression of diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S120-S122 |
artikel |
39 |
Nephrotoxicity and calcineurin inhibitors
|
Coates, P Toby H |
|
2007 |
|
s1 |
p. S85-S87 |
artikel |
40 |
Other agents
|
Johnson, David |
|
2006 |
|
s1 |
p. S46-S50 |
artikel |
41 |
Other forms of dietary intervention
|
Johnson, David |
|
2006 |
|
s1 |
p. S51-S54 |
artikel |
42 |
Parathyroid hormone
|
Elder, Grahame |
|
2006 |
|
s1 |
p. S209-S216 |
artikel |
43 |
Phosphate
|
Johnson, David |
|
2006 |
|
s1 |
p. S27-S29 |
artikel |
44 |
Pre-dialysis education for patients with chronic kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S46-S48 |
artikel |
45 |
Pregnancy
|
Johnson, David |
|
2006 |
|
s1 |
p. S41-S43 |
artikel |
46 |
Pregnancy, lactation and calcineurin inhibitors
|
Grimer, Marc |
|
2007 |
|
s1 |
p. S98-S105 |
artikel |
47 |
Prevention of recurrent calcium nephrolithiasis
|
Kairaitis, Lukas |
|
2007 |
|
s1 |
p. S11-S20 |
artikel |
48 |
Protein restriction to prevent the progression of diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S100-S104 |
artikel |
49 |
Radiological diagnosis of kidney stones
|
Richmond, John |
|
2007 |
|
s1 |
p. S34-S36 |
artikel |
50 |
Reducing proteinuria
|
Gillin, Adrian |
|
2006 |
|
s1 |
p. S66-S72 |
artikel |
51 |
Reflux nephropathy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S175-S181 |
artikel |
52 |
Regular and frequent follow-up of patients with pre-end-stage kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S44-S45 |
artikel |
53 |
Renal artery stenosis
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S126-S131 |
artikel |
54 |
Serum phosphate
|
Hawley, Carmel |
|
2006 |
|
s1 |
p. S201-S205 |
artikel |
55 |
Smoking
|
Johnson, David |
|
2006 |
|
s1 |
p. S44-S45 |
artikel |
56 |
Smoking and the progression of diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S114-S115 |
artikel |
57 |
Specific effects of calcium channel blockers in diabetic nephropathy
|
Nicholls, Kathy |
|
2006 |
|
s1 |
p. S105-S108 |
artikel |
58 |
Specific management of IgA nephropathy: role of cyclosporin and other therapies
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S149-S153 |
artikel |
59 |
Specific management of IgA nephropathy: role of fish oil
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S137-S140 |
artikel |
60 |
Specific management of IgA nephropathy: role of steroid therapy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S132-S136 |
artikel |
61 |
Specific management of IgA nephropathy: role of tonsillectomy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S146-S148 |
artikel |
62 |
Specific management of IgA nephropathy: role of triple therapy and cytotoxic therapy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S141-S145 |
artikel |
63 |
The addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients
|
Webster, Angela C |
|
2007 |
|
s1 |
p. S75-S84 |
artikel |
64 |
Therapeutic drug monitoring
|
Trevillian, Paul |
|
2007 |
|
s1 |
p. S57-S65 |
artikel |
65 |
Treatment of secondary membranous nephropathy
|
Thomas, Merlin |
|
2006 |
|
s1 |
p. S170-S171 |
artikel |
66 |
Uric acid
|
Johnson, David |
|
2006 |
|
s1 |
p. S25-S26 |
artikel |
67 |
Uric acid stones
|
Becker, Gavin |
|
2007 |
|
s1 |
p. S21-S25 |
artikel |
68 |
Use of calcimimetic drugs
|
Elder, Grahame |
|
2006 |
|
s1 |
p. S240-S244 |
artikel |
69 |
Use of phosphate binders in chronic kidney disease
|
Branley, Pauline |
|
2006 |
|
s1 |
p. S245-S262 |
artikel |
70 |
Vitamin D in dialysis patients
|
Faull, Randall |
|
2006 |
|
s1 |
p. S230-S239 |
artikel |
71 |
Weight reduction in obese patients with chronic kidney disease
|
Thomas, Merlin C |
|
2007 |
|
s1 |
p. S49-S51 |
artikel |